线性免疫分析法确认和区分巴西不确定Western blot血清样本中HTLV感染
该研究评估线性免疫分析(LIA)在巴西不同风险组中确认和区分HTLV-1/2感染的能力,样本来自WB不确定或无法分型的血清。结果显示LIA在G1、G2、G3组中分别确认66.1%、83.3%、76.0%的HTLV-1/2感染,且多数WB不确定样本在G1和G2中为HTLV-2阳性,G3中为HTLV-1或HTLV阳性。结论认为LIA是确认HTLV-1/2感染的最佳血清学检测方法。
要点
- LIA可提高WB不确定或无法分型样本的HTLV确认率,各组为66.1%、83.3%、76.0%。
- G1和G2中多数WB不确定样本经LIA确认为HTLV-2阳性,G3中为HTLV-1或HTLV阳性。
- LIA适用于HTLV单一感染或合并感染个体,是确认HTLV-1/2感染的最佳血清学检测。
核心结论
- LIA能有效确认和区分WB不确定或无法分型的HTLV-1/2感染,且不受合并感染影响。
研究设计与样本
- 研究分析三组样本:G1为62例来自圣保罗HIV/AIDS患者的样本(48例WB不确定,14例HTLV无法分型);G2为24例来自圣保罗乙肝或丙肝患者的样本(21例WB不确定,3例HTLV无法分型;17例HIV血清阳性);G3为25例来自萨尔瓦多HTLV门诊的样本(16例WB不确定,9例HTLV无法分型;所有HIV血清阴性)。
主要发现
- LIA在G1中确认66.1%的样本为HTLV-1/2感染(HTLV-1、HTLV-2或HTLV)。
- LIA在G2中确认83.3%的样本为HTLV-1/2感染。
- LIA在G3中确认76.0%的样本为HTLV-1/2感染。
关键数值与推荐
- LIA确认HTLV-1/2感染的比例:G1为66.1%,G2为83.3%,G3为76.0%。
临床怎么用
- 对于WB不确定或无法分型的血清样本,可使用LIA进行HTLV-1/2的确认和分型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Difficulties in confirming and discriminating human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by serological Western blot (WB) assays (HTLV Blot 2.4; MP Biomedicals) have been reported in Brazil, mainly in HIV/AIDS patients, with a large number of WB-indeterminate and WB-positive but HTLV-untypeable results. Nonetheless, a line immunoassay (LIA) (INNO-LIA HTLV-I/II; Fujirebio) provided enhanced specificity and sensitivity for confirming HTLV-1/2 infections. To add information concerning the improved ability of the LIA in relation to WB when applied to samples of individuals from different risk groups from Brazil, we performed the present study. Three groups were analyzed: group 1 (G1), with 62 samples from HIV/AIDS patients from São Paulo, SP (48 WB indeterminate and 14 HTLV untypeable); group 2 (G2), with 24 samples from patients with hepatitis B or hepatitis C from São Paulo (21 WB indeterminate and 3 HTLV untypeable; 17 HIV seropositive); and group 3 (G3), with 25 samples from an HTLV outpatient clinic in Salvador, Bahia (16 WB indeterminate and 9 HTLV untypeable; all HIV seronegative). Overall, the LIA confirmed HTLV-1/2 infection (HTLV-1, HTLV-2, or HTLV) in 66.1% (G1), 83.3% (G2), and 76.0% (G3) of samples. Interestingly, the majority of WB-indeterminate results were confirmed by the LIA as being HTLV-2 positive in G1 and G2 but not in G3, in which the samples were defined as being HTLV-1 or HTLV positive. These results agree with the virus types that circulate in such patients of different regions in Brazil and emphasize that the LIA is the best serological test for confirming HTLV-1 and HTLV-2 infections, independently of being applied in HTLV-monoinfected or HTLV-coinfected individuals.
引用
- Campos KR, Santos FLN, da Silva Brito V, et al. Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil. J Clin Microbiol. 2019. PMID: 31597749. doi:10.1128/JCM.01384-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。